OBJECTIVE: To elucidate the regulation of the nitric oxide (NO) and carbon monoxide (CO) pathways in preeclampsia and to evaluate the ratio of asymmetric dimethylarginine (ADMA) to symmetric dimethylarginine (SDMA) as a marker for preeclampsia. METHODS: Maternal plasma and placental samples were obtained from 20 participants with preeclampsia and 23 controls. Enzyme-linked immunosorbent assay was used to measure plasma NO, ADMA, and SDMA as well as placental NO and hemeoxygnase 1 (HO-1). Western blot was used to measure placental dimethylarginine dimethylaminotransferases (DDAH-I and DDAH-II). RESULTS: Placental DDAH-I, placental DDAH-II, placental NO, and placental HO-1 were significantly decreased in participants with preeclampsia. While ADMA and SDMA levels were decreased in preeclampsia, the ADMA-SDMA ratio was not significantly different. CONCLUSIONS: Decreased DDAH and HO with preeclampsia suggest that they are important points in the regulatory pathways of NO and CO production that are altered in preeclampsia. The ADMA-SDMA ratio is not a useful test for preeclampsia.
OBJECTIVE: To elucidate the regulation of the nitric oxide (NO) and carbon monoxide (CO) pathways in preeclampsia and to evaluate the ratio of asymmetric dimethylarginine (ADMA) to symmetric dimethylarginine (SDMA) as a marker for preeclampsia. METHODS: Maternal plasma and placental samples were obtained from 20 participants with preeclampsia and 23 controls. Enzyme-linked immunosorbent assay was used to measure plasma NO, ADMA, and SDMA as well as placental NO and hemeoxygnase 1 (HO-1). Western blot was used to measure placental dimethylarginine dimethylaminotransferases (DDAH-I and DDAH-II). RESULTS: Placental DDAH-I, placental DDAH-II, placental NO, and placental HO-1 were significantly decreased in participants with preeclampsia. While ADMA and SDMA levels were decreased in preeclampsia, the ADMA-SDMA ratio was not significantly different. CONCLUSIONS: Decreased DDAH and HO with preeclampsia suggest that they are important points in the regulatory pathways of NO and CO production that are altered in preeclampsia. The ADMA-SDMA ratio is not a useful test for preeclampsia.
Authors: Renke Maas; Rainer H Böger; Edzard Schwedhelm; Juan P Casas; Patricio López-Jaramillo; Norma Serrano; Luis A Díaz Journal: JAMA Date: 2004-02-18 Impact factor: 56.272
Authors: J Ellis; U B Wennerholm; A Bengtsson; H Lilja; A Pettersson; B Sultan; M Wennergren; H Hagberg Journal: Acta Obstet Gynecol Scand Date: 2001-07 Impact factor: 3.636
Authors: Brian E McLaughlin; Gendie E Lash; Graeme N Smith; Gerald S Marks; Kanji Nakatsu; Charles H Graham; James F Brien Journal: Exp Biol Med (Maywood) Date: 2003-05
Authors: Felipe Vadillo-Ortega; Otilia Perichart-Perera; Salvador Espino; Marco Antonio Avila-Vergara; Isabel Ibarra; Roberto Ahued; Myrna Godines; Samuel Parry; George Macones; Jerome F Strauss Journal: BMJ Date: 2011-05-19
Authors: Andrey S Glotov; Evgeny S Tiys; Elena S Vashukova; Vladimir S Pakin; Pavel S Demenkov; Olga V Saik; Timofey V Ivanisenko; Olga N Arzhanova; Elena V Mozgovaya; Marina S Zainulina; Nikolay A Kolchanov; Vladislav S Baranov; Vladimir A Ivanisenko Journal: BMC Syst Biol Date: 2015-04-15
Authors: Lissette C Sánchez-Aranguren; Carlos E Prada; Carlos E Riaño-Medina; Marcos Lopez Journal: Front Physiol Date: 2014-10-10 Impact factor: 4.566